Dry eyes secondary to blepharitis and or meibomian gland dysfunction, though extremely common, is an annoyingly difficult condition to treat for several patients. Part of this difficulty lies in the inability of most patients to follow intensive and often times...
1 April 2014
| Stephen McPherson, John Olson
|
EYE - Cornea
Historically, in NHS Grampian, ophthalmology and optometry worked separately, with even the process of optometry referral to hospital occurring only at the behest of the patient’s general practitioner (GP). Criteria for referral were not discussed and feedback after referral was...
Syphilis has re-emerged as a significant public health concern, with the World Health Organization (WHO) estimating that 8 million adults aged 15–49 acquired syphilis in 2022. Untreated syphilis can have severe consequences, including cardiovascular, neurological and ocular complications. Ocular manifestations...
21 October 2020
| Marion Sikuade, Jennifer HY Tan, Zanna Currie
|
EYE - Oculoplastic
Due to the COVID-19 pandemic, the use of facemasks or face coverings in the clinical setting has become necessary. It is important to recognise that facemasks can be a source of infection after eye surgery and consider ways to minimise...
Diabetic retinopathy (DR) is the most common form of diabetic eye disease, characterised by exudates, microaneurysms and haemorrhage. Early diagnosis is crucial for preventing visual loss. The risk of developing diabetic retinopathy is known to increase with age as well...
Despite the clinical weight of the field, ophthalmology was a specialty we encountered infrequently during our early medical training. In spite of limited formal exposure during undergraduate and postgraduate training, eye-related presentations were a regular feature of our day-to-day work...
Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...
This column is often, but not always, about ophthalmic tech. This is one of those ‘not always’ editions. Time to share some interesting or useful things from the internet which can help in a number of ways, from preparing presentations...
Professor Sunil Shah has racked up his air miles in recent years. Since 2016, the Consultant Ophthalmologist at Midland Eye and the Birmingham & Midland Eye Centre, has become a repeat visitor to Cambodia where he has led a series...
Syed Irtiza Ali Shah explores this rare and unusual condition through a fascinating case presentation. Vasoproliferative tumours of the retina (VPTR) are a vascular mass with an associated exudative retinopathy alongside the presence of minimally dilated feeder vessels. This is...
Leading sight loss charity RNIB (Royal National Institute of Blind People) and The&Partnership has today (3 October 2022) launched a new campaign ‘See the person, not the sight loss’, challenging outdated public attitudes and misperceptions of sight loss.